PATENT CLAIM ANALYSIS

Application Number: 16066341
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["544", "278000"]

Abstract:
The present invention relates to crystalline forms of N-( 3 -( 2 -( 4 -( 4 -methylpiperazin- 1 -yl)phenylamino)thieno[ 3,2 -d]pyrimidin- 4 -yloxy)phenyl)acrylamide, and pharmaceutical compositions containing the same. The crystalline forms can be easily used for the preparation of a pharmaceutical composition containing the same as an active ingredient.

Claim (Index 4):
The crystalline form of  claim 3 , wherein the hydrate is a dihydrate or a trihydrate.

Metadata:
- Claim Count in Document: 16.0
- Percentile: 94.0
- Lexical Diversity: 1.41667
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14616548', '15801152', '14620970', '15845837', '14693015']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.778741344345302
- 35 USC 102 Novelty (BERT): 0.5152699398358509
- Combined Prediction Score: 0.7523942038943568
- Mean Citation Score: 290.769948
- Max Citation Score: 304.5352200000001
- Similarity Product: 207.33729524505625

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test